[144] Okta, Inc. SEC Filing

Rhea-AI Filing Summary

Okta, Inc. filed a Form 144 notifying of a proposed sale of 6,091 common shares valued at $548,190, to be sold on 09/18/2025 on NASDAQ. The shares were reported as acquired the same day, 09/15/2025, as Restricted Stock Units from the issuer and paid on 09/15/2025. The filing also discloses three prior 10b5-1 sales by Jonathan James Addison in July 2025 totaling 18,027 shares for aggregate gross proceeds of $1,729,956.48. The filer certifies no undisclosed material adverse information and references Rule 10b5-1 trading-plan representations.

Positive

• Required insider disclosure provided: Proposed sale of 6,091 shares and prior 10b5-1 transactions are transparently reported
• Broker and exchange specified: Morgan Stanley Smith Barney LLC and NASDAQ listed for the proposed sale
• Acquisition method disclosed: Shares were acquired as Restricted Stock Units on 09/15/2025

Negative

• Insider sales reported: Three 10b5-1 sales in July 2025 totaled 18,027 shares for $1,729,956.48 in gross proceeds
• No financial context provided: Filing contains no revenue, earnings, or ownership percentage details to assess impact

Insights

Securities Analyst

TL;DR: Routine insider Form 144 disclosing a planned disposition of newly vested RSUs and recent 10b5-1 sales; no earnings or operational data provided.

The filing lists a proposed sale of 6,091 common shares valued at $548,190, with acquisition dated 09/15/2025 as Restricted Stock Units. Material for investors: this is a disclosure of an insider sale rather than a corporate event. The filing also lists three 10b5-1 sales by Jonathan James Addison in July 2025 totaling 18,027 shares for $1,729,956.48 in gross proceeds. There is no accompanying financial performance information or commentary on use of proceeds, so impact on share count or ownership percentages cannot be assessed from this notice alone.

Corporate Governance Expert

TL;DR: Governance disclosure indicates compliance with Rule 144 and 10b5-1 reporting; signer affirms no undisclosed material information.

The Form 144 provides required transparency for an insider sale and confirms representations tied to Rule 10b5-1 where applicable. It documents the securities class, broker (Morgan Stanley Smith Barney LLC), sale venue (NASDAQ), and dates of acquisition and proposed sale. The filing includes the statutory certification that the selling person does not possess undisclosed material adverse information. No governance issues, departures, or litigation items are mentioned in the document.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6091	548190.00	168459019	09/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Restricted Stock Units	Issuer			6091	09/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JONATHAN JAMES ADDISON 100 First Street, Suite 600 San Francisco CA 94105	Common	07/25/2025	9000	900000.00
10b5-1 Sales for JONATHAN JAMES ADDISON 100 First Street, Suite 600 San Francisco CA 94105	Common	07/15/2025	3000	275433.30
10b5-1 Sales for JONATHAN JAMES ADDISON 100 First Street, Suite 600 San Francisco CA 94105	Common	07/14/2025	6027	554523.18

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Okta's Form 144 disclose about the proposed sale of shares?

The filing reports a proposed sale of 6,091 common shares valued at $548,190, to be sold on 09/18/2025 on NASDAQ.

How were the 6,091 Okta shares acquired according to the filing?

The shares were acquired as Restricted Stock Units from the issuer on 09/15/2025 and payment is listed as 09/15/2025.

What recent insider sales are disclosed in the Form 144 for OKTA?

Three 10b5-1 sales by Jonathan James Addison in July 2025: 7/25/2025 — 9,000 shares for $900,000.00; 7/15/2025 — 3,000 shares for $275,433.30; 7/14/2025 — 6,027 shares for $554,523.18.

Which broker is handling the proposed Okta share sale?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, New York, NY.

Does the Form 144 state whether the seller knows any undisclosed material information?

Yes. The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.